Cargando…
Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
BACKGROUND: Patient derived xenografts (PDX) are generated by transplanting the original patient’s tumor tissue into immune-deficient mice. Unlike xenograft models derived from cell lines, PDX models can better preserve the histopathology from the original patient and molecular pathways. High-grade...
Autores principales: | Dong, Ruifen, Qiang, Wenan, Guo, Haiyang, Xu, Xiaofei, Kim, J. Julie, Mazar, Andrew, Kong, Beihua, Wei, Jian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031262/ https://www.ncbi.nlm.nih.gov/pubmed/27655386 http://dx.doi.org/10.1186/s13045-016-0318-6 |
Ejemplares similares
-
miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
por: Dong, Ruifen, et al.
Publicado: (2014) -
Tubal Origin of “Ovarian” Low-Grade Serous Carcinoma: A Gene Expression Profile Study
por: Wang, Yiying, et al.
Publicado: (2019) -
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
por: Kleinmanns, Katrin, et al.
Publicado: (2020) -
IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer
por: Dongol, Samina, et al.
Publicado: (2020) -
Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)